Title: Parallel Trade and the Pricing of Pharmaceutical Products
1Parallel Trade and the Pricing of Pharmaceutical
Products
Conference on Health Economics and the
Pharmaceutical Industry
2Agenda
- 1 Introduction
- 2 Prior literature
- Double marginalization model with complete
information - Conclusion and ideas for further research
3Parallel imports (PIs)
- When do parallel imports actually occur?
- Why should we care about parallel imports?
- - Advocates of strong patent rights for new
pharmaceutical products support a global regime
of banning parallel imports - - Restraints on parallel imports vary widely
between developed and developing countries and
even amongst developed countries
4Questions to be analyzed
- Why may parallel imports actually occur in
equilibrium when information is complete? - Are parallel imports beneficial or detrimental to
the producer of a patented product?
5Agenda
- 1 Introduction
- 2 Prior literature Determinants of parallel
trade - Double marginalization model with complete
information - Conclusion and ideas for further research
6Determinants of Parallel Trade
- First strand of literature
- Exclusive distribution rights in foreign
markets, vertical price control and parallel
trade Maskus and Chen (2002, 2004)
7Determinants of Parallel Trade
- Second strand of literature
- Price regulations by national governments and
parallel trade Ganslandt and Maskus (2004),
Jelovac and Bordoy (2005)
8Agenda
- 1 Introduction
- 2 Prior literature
- Double marginalization model with complete
information - Conclusion and ideas for further research
9Double Marginalization Game Assumptions
- Player 1 Monopolistic manufacturer of
pharmaceuticals in country A - Manufacturer has marginal costs of zero
- Player 2 Exclusive distributor in country B
- Players payoff functions their profits
- Demand in country A
- Demand in country B
- Parallel imports are allowed (perfect substitute)
- Distributor marginal costs of parallel trade,
10Structure of the game
- First stage manufacturer chooses the wholesale
price at which he sells the pharmaceutical
product to the distributor in country B, - Second stage distributor chooses the retail
price in country B, pB - Third stage manufacturer and distributor
simultaneously choose the prices at which they
sell the product in country A in a Bertrand price
competition, and .
11Bertrand price competition
- Rules of the game
- The low-price firm serves the entire market
- The high-price firm sells nothing
- Manufacturer has marginal costs of zero
- Distributor has positive marginal costs of
-
- Manufacturer sets a price that is smaller than
the marginal costs of the distributor,
12Bertrand price competition
Result PIs will never occur in any sub-game
perfect Nash equilibrium in the double
marginalization game with complete information
13Distributors decision
- In the second stage, the distributor anticipates
that he will be driven out of the market in
country A in the third stage - In the second stage, the distributor sets a
retail price in country B that is 50 per cent
higher than the wholesale price set by the
manufacturer
14Maximization problem of the manufacturer
15Solution 1 for low trade costs and high
- We use the Kuhn-Tucker Theorem and obtain two
solutions - Solution 1
- Solution 1 only satisfies the non-negativity
restrictions - if
16Solution 2 for
- equal to the monopoly price in the double
marginalization game when parallel imports are
prohibited - equal to the profit-maximizing wholesale price in
the double marginalization game when parallel
imports are prohibited
17Equilibrium Quantities and Prices
PIs allowed PIs prohibited
Price in A
Quantity in A
Wholesale Price in B
Retail Pr. in B
Quantity in B
18Profit of the manufacturer
- Parallel imports are allowed
- 2. Parallel imports are prohibited
19Net effect on profit when PIs are allowed
20Net effect on profit when PIs are allowed
- For we obtain
- Hence,
- Result Manufacturer generates a lower profit
when parallel imports are allowed
21Results of the welfare analysis
- The net effect of parallel trade on global
welfare is positive if the market in country A is
large - ( )
- The net effect of parallel trade on global
welfare can be negative if trade costs are at an
intermediate level and countries are virtually
homogenous in terms of market size ( )
22Summary of the main results
- PIs will never occur in a double marginalization
game with complete information - If , potential competition
from parallel trade does not arise. The
manufacturer charges the monopoly price in
country A and the optimal wholesale price in
country B - If , potential competition from
parallel trade arises. The manufacturer
strategically sets the wholesale price in country
B and the price in country A, in order to prevent
that parallel trade occurs
23Summary of the main results
- The manufacturer generates a lower profit when
parallel imports are allowed as he has to set
prices strategically in order to deter parallel
imports
24Agenda
- 1 Introduction
- 2 Prior literature
- Double marginalization model with complete
information - Ideas for further research
25Ideas for further research
- Does parallel trade occur when country A is less
attractive in terms of market size,
, and trade costs are very low - ?
- Impact of a price cap in country B?
26Ideas for further research
- Parallel trade and medicines for neglected
infectious and tropical diseases - - 99 per cent of global demand for medicines
for such diseases is generated in the developing
world - - Country A high-income country
- - Country B low-income country
-
27 28Follow-up paper New timing of the game
- Stage 0 Manufacturer chooses retail price in
country A - Stage 1 Manufactuer chooses wholesale price in
country B - Stage 2 Distributor chooses retail price in
country B - Stage 3 If , a third firm will
enter the market, buys the product from the
distributor in country B and then re-sells the
product in country A
29Game with asymmetric information
- First stage Manufacturer chooses the price at
which he charges the distributor in country B - Second stage Nature chooses the demand in
country A and country B - Third stage Distributor chooses the price he
charges his customers in country B - Fourth stage Manufacturer and distributor play a
Bertrand game
30Hypothesis
-
- Depending on Natures choices with regard to
local demand functions parallel imports may occur
in equilibrium
31Social welfare analysis of parallel imports
- Infectious diseases kill 14 million people around
the world every year, with 90 per cent of those
deaths occurring in the developing world - Furthermore, almost 1,400 new medicines have been
developed in the last 25 years, but only 1 per
cent of these were medicines for parasitic and
infectious tropical diseases that are rampant in
the developing world
32Hypothesis
- Hypothesis There is an important rationale for
restricting parallel importation of medicines for
parasitic and infectious tropical diseases that
are rampant in middle income and low income
countries - Parallel imports would further reduce the
incentives to invest in RD for medicines for
parasitic and infectious tropical diseases
33Parallel Imports and the WTO
- WTO members are free to choose whether to allow
or prohibit parallel imports - Article 6 of the TRIPS Agreement
- For the purposes of dispute settlement under
this Agreement, subject to the provisions of
Articles 3 and 4, nothing in this Agreement shall
be used to address the issue of the exhaustion of
intellectual property rights.
34Distributors decision
- In the second stage, the distributor anticipates
that he will be driven out of the market in
country A in the third stage - Parallel trade does not occur
- Total profit is equal to the profit generated in
country B through exclusive distribution
35Distributors decision
- The distributor has to pay the wholesale price
- Maximizes profit according to
36Distributors decision
- The first-order condition is given by
-
37Parallel trade can have a negative effect on
global welfare , and